March 17, 2025
The University of Cincinnati's Yasmin Aziz was featured in a MedCentral article discussing the recent FDA approval of the drug tenecteplase for treatment of acute ischemic stroke.
March 12, 2025
The University of Cincinnati is one of four new national institutions to receive $2.3 million each to join the Breakthrough Discoveries for Thriving with Bipolar Disorder (BD²) Integrated Network, a collaborative research and clinical care model with a mission to improve care, interventions and outcomes for people living with bipolar disorder.
March 7, 2025
MSN highlighted a new University of Cincinnati Cancer Center clinical trial aimed to optimize pain management and reduce the need for opioids after mastectomy procedures.
March 5, 2025
A multidisciplinary team of University of Cincinnati Cancer Center researchers is leading a new clinical trial aimed to optimize pain management and reduce the need for opioids after mastectomy procedures.
March 4, 2025
The University of Cincinnati's Paul Wechsler joined Fox 19 to discuss the connection between heart health and brain health.
March 3, 2025
Spectrum News highlighted the experiences of student Mikiahya Greene, a new recruit to the UC Adaptive Athletics track and field team.
February 27, 2025
The University of Cincinnati's Eva Mistry was featured in a Spectrum News story discussing how stroke awareness can save lives in light of a new bill introduced in the Ohio Legislature to designate the first week of May as Stroke Awareness Week.
February 26, 2025
The University of Cincinnati, Adams County Health Department and other partners in Ohio are testing a new collaborative care model that aims to remove barriers and provide more students access to telemental health care.
February 24, 2025
A new University of Cincinnati trial will compare brain accessibility of two types of omega-3 supplements in elderly adults at risk for dementia.
February 20, 2025
Renal + Urology News highlighted research led by the University of Cincinnati's Alberto Martini that found using antihistamines in patients receiving second-line immunotherapy for a certain bladder cancer may improve outcomes.